Phase 3 TRIUMPH-4 demonstrated 28.7% mean weight loss at 68 weeks with the 12 mg dose, confirming the exceptional Phase 2 results (24.2% at 48 weeks
AOD 9604 is usually provided via subcutaneous injections, often combined with other weight-loss management in participants who find it challenging to lose stubborn fat or have metabolism slowdowns
Recommended Source BPC-157 is available in 5 mg vials from Heritage Labs USA, a U.S.-based research peptide supplier with batch-level purity verification
Research peptides and compounds are intended strictly for laboratory research and are not for human consumption or for the diagnosis, treatment, or prevention of any disease
RECONSTITUTION DSIP is supplied as a lyophilized (freeze-dried) powder and requires reconstitution with sterile water
After 72 h, the resulting solution was freeze-dried by using low-temperature freeze dryers, yielding P1(1.23 g) as a yellow powder